Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 67048-1-Ig - Provider product page

- Provider
- Proteintech Group
- Product name
- Cyclin D2 antibody
- Antibody type
- Monoclonal
- Description
- Cyclin D2 antibody (Cat. #67048-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, mouse and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1A12A8
- Vial size
- 20ul, 150ul
Submitted references Effects of ADRM1 on osteoblast differentiation and mineralization in osteoporosis.
Protein arginine methyltransferase 7 regulates the cell cycle and promotes the progression of prostate cancer.
Avermectin B1 mediates antitumor activity and induces autophagy in osteosarcoma through the AMPK/ULK1 signaling pathway.
USP13 deubiquitinates and stabilizes cyclin D1 to promote gastric cancer cell cycle progression and cell proliferation.
Hydroxypropyl-β-cyclodextrin inhibits the development of triple negative breast cancer by enhancing antitumor immunity.
miR-1297 inhibits osteosarcoma cell proliferation and growth by targeting CCND2.
Long intergenic non-coding RNA 00473 promotes proliferation and migration of gastric cancer via the miR-16-5p/CCND2 axis and by regulating AQP3.
The Analysis of Differentially Expressed circRNAs Under the Antiproliferative Effect From 5-Fluorouracil on Osteosarcoma Cells.
Zhuang H, Lin Y, Lin C, Zheng M, Yao X, Xu Y
American journal of translational research 2025;17(1):416-428
American journal of translational research 2025;17(1):416-428
Protein arginine methyltransferase 7 regulates the cell cycle and promotes the progression of prostate cancer.
Wan H, Zhou H, Gui J, Yang D, Wang R, Ni J, Wu S, Qin Y, Qi Q, Zhu L, Feng N, Mi Y
Oncology letters 2025 Dec;30(6):549
Oncology letters 2025 Dec;30(6):549
Avermectin B1 mediates antitumor activity and induces autophagy in osteosarcoma through the AMPK/ULK1 signaling pathway.
Fei X, Li Z, Pan Z, Liang Y, Tan C, Cheng D, Yang Q
Cancer chemotherapy and pharmacology 2024 Oct;94(4):599-613
Cancer chemotherapy and pharmacology 2024 Oct;94(4):599-613
USP13 deubiquitinates and stabilizes cyclin D1 to promote gastric cancer cell cycle progression and cell proliferation.
Ma C, Wang D, Tian Z, Gao W, Zang Y, Qian L, Xu X, Jia J, Liu Z
Oncogene 2023 Jul;42(29):2249-2262
Oncogene 2023 Jul;42(29):2249-2262
Hydroxypropyl-β-cyclodextrin inhibits the development of triple negative breast cancer by enhancing antitumor immunity.
Zhu M, Zhao Q, Zhang W, Xu H, Zhang B, Zhang S, Duan Y, Liao C, Yang X, Chen Y
International immunopharmacology 2023 Dec;125(Pt A):111168
International immunopharmacology 2023 Dec;125(Pt A):111168
miR-1297 inhibits osteosarcoma cell proliferation and growth by targeting CCND2.
Jiang P, Mao L, Lei X, Luo C, Zhang Y, Zhong X, Yin Z, Xu X, Li D, Zheng Q
American journal of cancer research 2022;12(7):3464-3478
American journal of cancer research 2022;12(7):3464-3478
Long intergenic non-coding RNA 00473 promotes proliferation and migration of gastric cancer via the miR-16-5p/CCND2 axis and by regulating AQP3.
Zhuo S, Sun M, Bai R, Lu D, Di S, Ma T, Zou Z, Li H, Zhang Z
Cell death & disease 2021 May 15;12(5):496
Cell death & disease 2021 May 15;12(5):496
The Analysis of Differentially Expressed circRNAs Under the Antiproliferative Effect From 5-Fluorouracil on Osteosarcoma Cells.
Huang A, Chen L, Wang Y, Ma S, Jin S, Cai H, Huang X, Zhang H, Wang Z, Lin K, Lin F
Technology in cancer research & treatment 2020 Jan-Dec;19:1533033820964215
Technology in cancer research & treatment 2020 Jan-Dec;19:1533033820964215
No comments: Submit comment
No validations: Submit validation data